•  
  •  
  •  
  •  

2025-12-04 19:56:16

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Supra Trends Ltd Launches New Brand – 'The South Factory'
  • Rail Vikas Nigam Ltd receives LOA from Southern Railway
  • Veritas India Ltd to dispose certain assets of subsidiary Verasco FZE
  • Reliance Industries Ltd and Surrey announce their partnership in Oval Invincibles franchise in The Hundred
  • Sugs Lloyd Ltd secures ₹43.37 Crore Order from Punjab State Power Corporation Ltd

Keywords Selected:  JubilantPharmova

Stock Report

  • Appointment of Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc.
  • Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores
  • Jubilant HollisterStier LLC launches New High-Speed Isolator based Line, at its Spokane Manufacturing Facility in the US
  • Jubilant Pharmova announces Completion of Pharmacovigilance Inspection by the USFDA with No Observations
  • Jubilant Pharmova Ltd consolidated Q1 FY2025-26 profit slides to Rs. 102.9 crores
  • Jubilant Pharmova Limited recommends final dividend of Rs. 5
  • Jubilant Pharmova Ltd Q4 FY2024-25 consolidated PAT climbs to Rs. 153.6 crores
  • Jubilant Cadista Pharmaceuticals Inc., USA's facility receives EIR from USFDA
  • Jubilant Cadista Pharmaceuticals Inc receives 5 observations from USFDA for Salisbury facility
  • USFDA Inspection at Jubilant HollisterStier General Partnership's Contract manufacturing facility at Montreal, Canada
  • Jubilant Pharmova announces completion of USFDA audit of facility Located at Spokane, Washington, USA
  • USFDA determines inspection classification of VAI for the contract manufacturing facility at Spokane, Washington
  • Jubilant Pharmova Ltd consolidated Q1 FY25 PAT surges to Rs. 482.1 crores
  • Jubilant Pharmova Ltd completes voluntary prepayment of USD 75 million term loan, equivalent to Rs. 626 Cr
  • Jubilant Pharmova announces completion of USFDA audit of contract manufacturing facility at Montreal, Canada
  • Jubilant's Radiopharma Business Announces Investment to Expand Positron Emission Tomography Radiopharmacy Network
  • Jubilant Pharmova Ltd announces voluntary prepayment of USD 75 million term loan, equivalent to Rs. 626 Cr
  • Jubilant Pharmova announces completion of USFDA audit of Radiopharmaceuticals manufacturing facility at Montreal, Canada
  • USFDA determines inspection classification of 'Voluntary Action Indicated' for the Solid dosage manufacturing facility at Roorkee, India
  • Jubilant Pharmova's wholly owned subsidiary to sell its entire 25.8% stake in Sofie Biosciences Inc., USA
  • Jubilant Pharmova Ltd reports consolidated Q1FY24 profit of Rs. 6.4 crores
  • Jubilant Pharmova Ltd Q4FY23 consolidated loss widens to Rs. 97.84 crores
  • Jubilant announces additional loan facility by Government of Canada for the Expansion of its CMO Montreal facility
  • USFDA assigns VAI classification to Jubilant Pharmova's API facility at Nanjangud

Latest Post

  • Supra Trends Ltd Launches New Brand – 'The South Factory'
  • Rail Vikas Nigam Ltd receives LOA from Southern Railway
  • Veritas India Ltd to dispose certain assets of subsidiary Verasco FZE
  • Reliance Industries Ltd and Surrey announce their partnership in Oval Invincibles franchise in The Hundred
  • Sugs Lloyd Ltd secures ₹43.37 Crore Order from Punjab State Power Corporation Ltd


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024